"Novel targeted therapy combinations to improve efficacy in BRAF and KRAS mutant cancers," Ryan Corcoran, MD, PhD

Thursday, January 3, 2013 at 3:00pm to 4:00pm

Dana-Farber Cancer Institute, Dana 1620 Dana-Farber Cancer Institute, Boston, MA, Boston, MA

"Novel targeted therapy combinations to improve efficacy in BRAF and KRAS mutant cancers," Ryan Corcoran, MD, PhDThe DFCI Division of Molecular and Cellular Oncology presents a special seminar by Ryan Corcoran. His talk is titled "Novel targeted therapy combinations to improve efficacy in BRAF and KRAS mutant cancers"

Share
Subscribe
Event Type

Basic Science, Clinical Research

Recent Activity

People Going

Getting Here


NCI CCC